top of page
Nelson Advisors > European HealthTech & MedTech


Founder Bankers and Banker Founders: New Competitive Advantages in European HealthTech and MedTech
Central to this transition is the emergence of the "Founder Banker," a new class of corporate financial advisor and entrepreneur who combines deep operational pedigree, having built, scaled and exited their own ventures, with sophisticated investment banking and private equity expertise. These individuals occupy a critical niche in the contemporary M&A landscape, bridging the widening gap between digital economy metrics and the complex, often opaque, regulatory realities of m
Nelson Advisors
May 411 min read


Evolution of the European HealthTech and MedTech Advisory Ecosystem: Rise of Founder Bankers and Specialist Boutiques
The European healthcare technology and medical device landscape has reached a definitive inflection point in 2026, transitioning from a decade of speculative, venture subsidised experimentation to an era of disciplined industrial maturity.
This transition is characterised by a fundamental shift away from the liquidity fuelled exuberance of the early 2020s toward a metrics driven environment where strategic value is defined by clinical utility, regulatory resilience and tec
Nelson Advisors
Apr 1711 min read


Founder Bankers and the Strategic Evolution of European HealthTech and MedTech Advisory
The European healthcare technology and medical device sectors have reached a definitive inflection point in 2026, transitioning from a decade of speculative, venture-subsidised experimentation to an era of disciplined industrial maturity. This report provides an analysis of the structural drivers of this consolidation, the emergence of the Founder Banker as the primary architect of liquidity and the technological and regulatory forces shaping the M&A landscape in 2026.
Nelson Advisors
Mar 2112 min read


Founder Bankers and Taxonomy of European Healthcare Technology Investment Banking Specialists
The European healthcare technology and medical technology sectors have reached a definitive inflection point in 2026, transitioning from a period of venture-subsidised experimentation to an era of disciplined industrial maturity. This shift is characterized by a "Great Rationalization," where the market has moved past the speculative exuberance of the early 2020s and settled into a rigorous "flight to quality". Central to this transformation is the emergence of the "Founder B
Nelson Advisors
Feb 2110 min read


Founder Bankers advising European HealthTech and MedTech in 2026
Firms like Nelson Advisors in the UK, Clipperton in France, and ConAlliance in the DACH region are at the forefront of this movement. These boutiques have redefined the advisory role by focusing on sub-sector granularity and "Founders for Founders" partnership models. They prioritise long-term strategic positioning over purely transactional outcomes, often helping founders navigate the transition from venture-backed growth to private equity platform consolidation.
Nelson Advisors
Jan 3110 min read
bottom of page